Central pulmonary embolism in patients with Covid-19

Martin Nordberg1, Sara Bankler2, Åsa H Everhov1,3

  • 1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Insights

Central pulmonary embolism (PE) was common in COVID-19 patients, particularly in intensive care units (ICU). However, central PE showed no association with prophylactic anticoagulation or the severity of lung changes from COVID-19.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • COVID-19 (Coronavirus Disease 2019) is associated with an increased risk of thrombotic events.
  • Pulmonary embolism (PE) is a significant complication in hospitalized COVID-19 patients.
  • Understanding the characteristics of PE in COVID-19 is crucial for patient management.

Purpose of the Study:

  • To evaluate the occurrence and characteristics of central pulmonary embolism (PE) in patients with COVID-19.
  • To assess the association between central PE and radiological lung changes, prophylactic anticoagulation, and intensive care unit (ICU) admission.

Main Methods:

  • Retrospective analysis of hospitalized patients with confirmed SARS-CoV-2 RNA.
  • Diagnosis of PE confirmed by computed tomography pulmonary angiography.
  • Assessment of COVID-19 related lung changes using a scoring system (max score 25).
  • Evaluation of anticoagulant regimens and ICU status.

Main Results:

  • A cumulative incidence of 3.5% for PE was observed in 1162 COVID-19 patients.
  • Central PE accounted for 63.4% of all PE cases, with 46.3% diagnosed at admission.
  • Central PE was significantly more frequent in ICU patients (82.4%) compared to non-ICU patients (50.0%).
  • No significant association was found between central PE and prophylactic anticoagulation (p=.317) or the extent of radiological lung changes (p=.451).

Conclusions:

  • A high proportion of central PE was observed in COVID-19 patients, especially those in the ICU.
  • Central PE frequently occurred at the time of hospital admission.
  • The extent of radiological lung changes and prophylactic anticoagulation did not correlate with the presence of central PE.
Abstract

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
242
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
108
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
122
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
744
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
586
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
573